Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer

OBJECTIVES: Patients hospitalised abroad can become colonised with multidrug-resistant bacteria and import them to their home countries. In this study, we characterised an OXA-484 carbapenemase-producing Escherichia coli strain from a Swiss patient infected by SARS-CoV-2 and repatriated from India....

Descripción completa

Detalles Bibliográficos
Autores principales: Moser, Aline I., Campos-Madueno, Edgar I., Sendi, Parham, Perreten, Vincent, Keller, Peter M., Ramette, Alban, Endimiani, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552635/
https://www.ncbi.nlm.nih.gov/pubmed/34718203
http://dx.doi.org/10.1016/j.jgar.2021.10.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552635/
https://www.ncbi.nlm.nih.gov/pubmed/34718203
http://dx.doi.org/10.1016/j.jgar.2021.10.012

Ejemplares similares